Drug intelligence / Profile preview

Yin Zhi Huang

Development stage
Phase 4
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Yin Zhi Huang is a traditional Chinese medicine formula composed of extracts from Artemisia capillaris (Yin Chin), Gardenia jasminoides (Zhi Zi), Scutellaria baicalensis (Huang Qin), and Lonicera japonica (Jin Yin Hua). It is widely used in China and other parts of Asia for the treatment and prevention of jaundice, particularly neonatal jaundice, as well as for liver disorders such as acute and chronic hepatitis. The main pharmacological actions include clearing heat, detoxifying the body, promoting bile secretion, reducing bilirubin levels, and alleviating symptoms associated with liver dysfunction. Mechanistically, Yin Zhi Huang accelerates bilirubin clearance by activating the constitutive androstane receptor (CAR/NR1I3) pathway in hepatocytes. This activation induces expression of enzymes involved in bilirubin metabolism such as UDP-glucuronosyltransferase 1A1 (UGT1A1). Other pathways implicated include AMPK/SREBP-1 and AMPK/ACC/CPT1A signaling relevant to hepatic lipid metabolism[6][8][10]. The active constituents identified include chlorogenic acid from Lonicera japonica; geniposide from Gardenia jasminoides; baicalin from Scutellaria baicalensis; coumarins; flavonoids; iridoid glycosides; organic acids[2]. Clinical indications are primarily for "liver-gallbladder damp-heat" syndromes manifesting as jaundice with yellowish skin or eyes, chest/flank pain or distension, nausea/vomiting, dark urine—corresponding to acute/chronic hepatitis or hyperbilirubinemia[5][7].

Brand names
茵栀黄
Other names
YZH茵栀黄口服液茵栀黄注射液
02

Targets

PRKAA2 (AMPK alpha-2)CXADR (Coxsackievirus and adenovirus receptor)

Beyond the preview

Go deeper on Yin Zhi Huang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yin Zhi Huang.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call